Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 184
Filter
1.
Clin Neuroradiol ; 33(4): 1123-1131, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37410170

ABSTRACT

PURPOSE: Acute traumatic osseous and cartilaginous injuries to the larynx are rare injuries presenting to the emergency department. Despite the low reported incidence, laryngeal trauma carries a high morbidity and mortality. The purpose of this study is to identify fracture and soft tissue injury patterns in laryngeal trauma and explore associations with patient demographics, mechanisms of injury, urgent airway and surgical intervention. METHODS: A retrospective review of patients with laryngeal injury who underwent multidetector computed tomography (MDCT) imaging was performed. The CT findings of laryngeal and hyoid fracture location, fracture displacement, and soft tissue injuries were recorded. Clinical data including patient demographics, mechanisms of injury, frequency of airway and surgical intervention were also recorded. Correlation of imaging characteristics with patient demographics, mechanism of injury and interventions were assessed for statistical significance using χ2 and Fisher's exact tests. RESULTS: The median patient age was 40 years old with a strong male predominance. The most common mechanisms of injury included motor vehicle collisions and penetrating gunshot wounds. Thyroid cartilage fractures were the most common fracture type. Findings of fracture displacement and airway hematoma had a higher correlation with requiring urgent airway management. CONCLUSION: Radiologists' early recognition and prompt communication of laryngeal trauma to the clinical service is important to reduce associated morbidity and mortality. Displaced fractures and laryngeal hematomas should be promptly conveyed to the clinical service as they are associated with more complex injuries and higher rates of urgent airway management and surgical intervention.


Subject(s)
Larynx , Spinal Fractures , Wounds, Gunshot , Wounds, Penetrating , Humans , Male , Adult , Female , Larynx/diagnostic imaging , Larynx/injuries , Multidetector Computed Tomography , Retrospective Studies
2.
Sep Purif Technol ; 294: 121180, 2022 Aug 01.
Article in English | MEDLINE | ID: mdl-35573908

ABSTRACT

The outbreak of SARS-CoV-2 pandemic highlighted the worldwide lack of surgical masks and personal protective equipment, which represent the main defense available against respiratory diseases as COVID-19. At the time, masks shortage was dramatic in Italy, the first European country seriously hit by the pandemic: aiming to address the emergency and to support the Italian industrial reconversion to the production of surgical masks, a multidisciplinary team of the University of Bologna organized a laboratory to test surgical masks according to European regulations. The group, driven by the expertise of chemical engineers, microbiologists, and occupational physicians, set-up the test lines to perform all the functional tests required. The laboratory started its activity on late March 2020, and as of the end of December of the same year 435 surgical mask prototypes were tested, with only 42 masks compliant to the European standard. From the analysis of the materials used, as well as of the production methods, it was found that a compliant surgical mask is most likely composed of three layers, a central meltblown filtration layer and two external spunbond comfort layers. An increase in the material thickness (grammage), or in the number of layers, does not improve the filtration efficiency, but leads to poor breathability, indicating that filtration depends not only on pure size exclusion, but other mechanisms are taking place (driven by electrostatic charge). The study critically reviewed the European standard procedures, identifying the weak aspects; among the others, the control of aerosol droplet size during the bacterial filtration test results to be crucial, since it can change the classification of a mask when its performance lies near to the limiting values of 95 or 98%.

3.
Cureus ; 14(2): e22231, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35340467

ABSTRACT

Objective The incidence of vestibular schwannomas is increasing, and the average tumor size at diagnosis is decreasing. Therefore, understanding the specific growth pattern of small vestibular schwannomas is becoming increasingly important to guide clinical management. The objectives of this study were to evaluate the growth patterns of very small intracanalicular vestibular schwannomas measuring ≤ 4 mm in linear diameter and to assess the likelihood of these lesions ever requiring treatment.  Methods A retrospective review was performed. A search of all MRI brain and internal auditory canal studies suggestive of a vestibular schwannoma from 1995 to 2019 was performed at our institution. This resulted in 372 cases, which were then evaluated for the presence of a vestibular schwannoma measuring ≤ 4 mm. All patients had to have at least one follow-up MRI to be included. Images were reviewed by a neuroradiologist. Results Eight ≤ 4 mm vestibular schwannomas were found that met all search criteria. The distribution of tumor sizes was as follows: three 2 mm, one 3 mm and four 4 mm. None of the ≤ 4 mm vestibular schwannomas identified demonstrated any significant growth in the linear dimension defined as greater than 2 mm of growth over observation times of 1-13 years (mean 6.3 years). None of the lesions ever required a treatment intervention per available medical records. Conclusion None of the ≤ 4 mm intracanalicular vestibular schwannomas identified in this study grew significantly or required treatment. Overall, the findings in this study suggest that vestibular schwannomas measuring ≤ 4 mm are unlikely to grow and ever require treatment.

4.
Environ Pollut ; 234: 969-978, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29665637

ABSTRACT

One of the main problems that arise in the assessment of air quality in an area is to estimate the number of representative sampling points of each microenvironment within it. We present a new model that reduces the variability and increases the quality of the comparison of the sampling points. The study is based on the comparison between a city in eastern Spain, Vila-real, a macro city in México, Monterrey and the Piemonte region regarding the assessment of PM10 in microenvironments. Vila-real is located in the province of Castellón. This province is a strategic area in the framework of European Union (EU) pollution control. On the other hand, Monterrey in México, located in the northern state of Nuevo León, has several problems with particulate material in the atmosphere produced by the extraction of building materials in the hill that surround the city. Finally, the Piemonte region, which is located in the north of Italy, has to be in consideration due to higher concentrations of PM10 in the Po river basin. In the case of Vila-real the PM10 samples were collected by a medium volume sampler according to European regulations. Particle concentration levels were determined gravimetrically (EN 12341:1999). In the case of Monterrey the PM10 concentrations were determined by Beta Ray Attenuation according to US-EPA regulations. In the Piemonte region, the average concentration of PM10 was also obtained by means of the Beta Ray Attenuation as well as using gravimetric instruments. The methodology carried out in this paper is a useful tool for developing future Air Quality Plans in other industrialised areas.


Subject(s)
Air Pollutants/analysis , Air Pollution/statistics & numerical data , Environmental Monitoring , Particulate Matter/analysis , Air Pollution/analysis , Cities , Dust , Industrial Development , Italy , Mexico , Particle Size , Spain
5.
Stem Cell Res ; 24: 155-159, 2017 10.
Article in English | MEDLINE | ID: mdl-29034884

ABSTRACT

Multiple sclerosis (MS) is considered a chronic autoimmune disease of the central nervous system that leads to gliosis, demyelination, axonal damage and neuronal death. The MS disease aetiology is unknown, though a polymorphism of the TNFRSF1A gene, rs1800693, is known to confer an increased risk for MS. Using retroviral delivery of reprogramming transgenes, we generated six MS patient-specific iPSC lines with two distinct genotypes, CC or TT, of the polymorphism rs1800693. iPSC lines had normal karyotype, expressed pluripotency genes and differentiated into the three germ layers. These lines offer a good tool to study MS pathomechanisms and for drug testing.


Subject(s)
Induced Pluripotent Stem Cells/metabolism , Multiple Sclerosis/genetics , Cell Line , Humans , Multiple Sclerosis/metabolism
7.
Neurol Sci ; 38(1): 83-91, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27624723

ABSTRACT

Dementia with Lewy bodies (DLB) causes elevated outlays for the National Health Systems due to high institutionalization rate and patients' reduced quality of life and high mortality. Furthermore, DLB is often misdiagnosed as Alzheimer's disease. These data motivate harmonized multicenter longitudinal cohort studies to improve clinical management and therapy monitoring. The Italian DLB study group of the Italian Neurological Society for dementia (SINdem) developed and emailed a semi-structured questionnaire to 572 national dementia centers (from primary to tertiary) to prepare an Italian large longitudinal cohort. The questionnaire surveyed: (1) prevalence and incidence of DLB; (2) clinical assessment; (3) relevance and availability of diagnostic tools; (4) pharmacological management of cognitive, motor, and behavioural disturbances; (5) causes of hospitalization, with specific focus on delirium and its treatment. Overall, 135 centers (23.6 %) contributed to the survey. Overall, 5624 patients with DLB are currently followed by the 135 centers in a year (2042 of them are new patients). The percentage of DLB patients was lower (27 ± 8 %) than that of Alzheimer's disease and frontotemporal dementia (56 ± 27 %) patients. The majority of the centers (91 %) considered the clinical and neuropsychological assessments as the most relevant procedure for a DLB diagnosis. Nonetheless, most of the centers has availability of magnetic resonance imaging (MRI; 95 %), electroencephalography (EEG; 93 %), and FP-CIT single photon emission-computerized tomography (SPECT; 75 %) scan for clinical applications. It will be, therefore, possible to recruit a large harmonized Italian cohort of DLB patients for future cross-sectional and longitudinal multicenter studies.


Subject(s)
Lewy Body Disease/diagnosis , Lewy Body Disease/therapy , Alzheimer Disease/diagnosis , Cohort Studies , Diagnosis, Differential , Disease Management , Humans , Italy , Research Design , Surveys and Questionnaires
8.
Transplant Proc ; 48(9): 3003-3005, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27932131

ABSTRACT

OBJECTIVES: The authors sought to check the frequency of biliary complications with the use of a T-tube. In 2012, throughout the year, it was carried out systematically in all liver transplantations regardless of the characteristics of the bile duct. Despite the long experience, biliary complications remain a common cause of postoperative morbidity and mortality. MATERIAL AND METHODS: In this study we compared complications in 23 consecutive transplantation cases using T-tube biliary anastomosis during the year 2012 with 23 consecutive transplantation cases without T-tube during the year 2013. We evaluated postoperative complications and long-term outcomes (for 2 years to 3 years). RESULTS: Of the 23 patients with anastomosis with a T-tube, 2 patients (8.69%) had biliary stricture that required prosthesis by endoscopic retrograde cholangiopancreatography, 1 of them (4.34%) was operated by incorrect placement of the T-tube, and in 4 patients (17.39%) bile leakage (endoscopic retrograde cholangiopancreatography prostheses in 3 cases and hepaticojejunostomy in 1). During follow-up at 3 years, only 2 patients had minimal bile duct dilatation without clinical relevance. In the patients who underwent transplantation without a T-tube, 18 (78.26%) had no complications, 3 (13.04%) showed stenosis (prosthesis placement), and 2 (8.69%) had bile leakage (hepaticojejunostomy and prosthesis). During follow-up at 2 years to 3 years, no patient had biliary dilatation or alteration of cholestatic parameters. In the comparative study of both groups we found no statistically significant differences. CONCLUSIONS: We have not seen an improvement in complications with the use of T-tube (69.56% vs. 78.23%) that encourage us to work systematically, although the small number of cases does not allow statistically significant conclusions.


Subject(s)
Bile Ducts/surgery , Liver Transplantation/adverse effects , Anastomosis, Surgical , Biliary Tract Diseases/etiology , Biliary Tract Diseases/surgery , Biliary Tract Surgical Procedures/instrumentation , Cholangiopancreatography, Endoscopic Retrograde/methods , Cholestasis/etiology , Constriction, Pathologic/etiology , Constriction, Pathologic/surgery , Female , Humans , Liver Transplantation/instrumentation , Liver Transplantation/methods , Male , Middle Aged , Postoperative Complications/etiology , Retrospective Studies , Stents
9.
J Eur Acad Dermatol Venereol ; 29(4): 767-76, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25284275

ABSTRACT

BACKGROUND: Published evaluations of skin disease signs and health-related quality of life (HRQoL) upon therapy withdrawal and retreatment in psoriatic patients are limited to results of drug withdrawal after short-term treatment. Analyses are lacking that evaluate patients' response to retreatment for patients treated successfully long-term. OBJECTIVE: To study the efficacy and safety of adalimumab in patients with long-term clinical responses to adalimumab who then discontinue therapy and are retreated with the same dosing regimen as the initial course. Skin disease signs and patients' HRQoL are evaluated. METHODS: This post hoc analysis of an open-label study (NCT00195676) included patients who had responded favourably to adalimumab during initial treatment (≥75% improvement in Psoriasis Area and Severity Index [PASI 75 response]) and had maintained good clinical response for an extended period (up to 252 weeks); patients had Physician's Global Assessment (PGA) 0 or 1 before treatment interruption. Following drug withdrawal (up to 40 weeks), all patients were retreated with adalimumab 80 mg initial dose, followed by 40 mg every-other-week for 16 weeks. PASI response and HRQoL were evaluated. RESULTS: Of the 133 patients in this analysis, 24 (18%) relapsed during therapy withdrawal. After 16 weeks of retreatment, 75% who relapsed and 89.9% who did not relapse, had a PASI 75 response; 89.5% achieved European Consensus Programme treatment goals after 16 weeks of retreatment. During drug withdrawal, HRQoL disproportionally worsened compared to skin disease signs; HROoL also considerably worsened for patients who did not relapse. Patients regained HRQoL upon retreatment with adalimumab. No new safety signals were identified in this study. CONCLUSION: Retreatment with adalimumab was successful in improving psoriasis skin signs and HRQoL in this subgroup with initial and extended responses to therapy followed by relapse after treatment withdrawal. Patient's HRQoL should be considered, as it may substantially worsen during therapy interruption.


Subject(s)
Adalimumab/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Psoriasis/drug therapy , Quality of Life , Adalimumab/adverse effects , Adult , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Female , Humans , Male , Middle Aged , Recurrence , Retreatment , Severity of Illness Index , Time Factors , Withholding Treatment
10.
Biomed Res Int ; 2014: 159765, 2014.
Article in English | MEDLINE | ID: mdl-25243117

ABSTRACT

BACKGROUND: Genomic studies have shown that gene expression profiles are similar in in situ (CIS) and invasive breast cancers, suggesting that several biofunctional modifications of the transformation process occur before or during the development of CIS lesion. METHODS: We investigated 3 biomarkers in 44 patients with CIS: TG2 (transglutaminase 2), HJURP (Holliday junction recognition protein), and HIF-1α (hypoxia inducible factor-1 alpha). RESULTS: TG2 was more highly expressed than the other two markers and significantly more so in stromal than in tumor cells. HIF-1α evaluation showed a higher expression in both tumor and stromal cells in patients with relapsed G3 tumors, indicating a potential role of this marker in CIS evolution. A greater than sevenfold higher risk of relapse (P = 0.050) was observed in patients highly expressing HJURP in stroma and a tenfold higher recurrence risk (P = 0.026) was seen in those with a higher stromal HIF-1α expression. An important increase in risk accuracy (AUC 0.80) was obtained when HIF-1α and HJURP were evaluated together. CONCLUSIONS: Despite the limited number of relapsed patients, we formulated some hypotheses on the factors responsible for malignant evolution and recurrence which are now being tested in a large case series with a longer follow-up.


Subject(s)
Biomarkers, Tumor/metabolism , Breast Neoplasms/metabolism , Carcinoma in Situ/metabolism , DNA-Binding Proteins/metabolism , Disease Progression , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Adult , Aged , Area Under Curve , Breast Neoplasms/pathology , Carcinoma in Situ/pathology , Female , Humans , Immunohistochemistry , Middle Aged , Recurrence , Stromal Cells/pathology
SELECTION OF CITATIONS
SEARCH DETAIL